INDV Q1 2026 Earnings EPS Beat Drives 437 Surprise as Stock Declines RenovoRx Q1 2026 Earnings EPS Miss as PreRevenue Biotech Continues Clinical Development TGT Q1 2026 Earnings EPS of 171 Highlights Resilient Operations Amid Modest Stock Decline PRHI Q1 2024 Earnings Significant EPS Beat Fails to Impress Markets TWFG Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction USCB Q1 2026 Earnings Earnings Beat Driven by Strong Net Interest Margin